血管外科手术中的心房动:关于患病率,发病率和结果影响的系统综述和元分析
Vincenzo L Malavasi1, Federico Muto1, Pietro A C M Ceresoli1
1Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.
Journal of cardiovascular medicine (Hagerstown, Md.)
|August 22, 2023
概括
心房动 (AF) 影响11.5%的血管外科手术患者,增加死亡率和中风风险. 在手术后的AF (POAF) 发生在3.6%,在内血管手术中发病率较低.
科学领域:
- 心脏病学 心脏病学
- 血管外科 血管外科
- 流行病学 流行病学
背景情况:
- 心房动 (AF) 是一种常见的心律失常.
- 手术后肌肉衰竭 (POAF) 是手术后的一种已知的并发症.
- 了解AF和POAF在血管外科手术中的患病率和结果至关重要.
研究的目的:
- 为了确定为动脉疾病进行血管外科手术的患者中AF病史的流行率.
- 为了确定这个患者群体中POAF的发病率.
- 评估AF和POAF对结果的影响.
主要方法:
- 进行了系统性审查和元分析.
- 从44个选定的记录中提取数据.
- 在审查过程中遵循了PRISMA指南.
主要成果:
- 肌前膜病史的患病率为11.5%,在内血管手术中更高. 肌痛前科与增加住院死亡和中风相关.
- 聚合的POAF发生率为3.6%.
- POAF的风险与年龄的增长有关,并且在内血管手术后,与开放手术相比,其风险较低.
结论:
- 血管外科手术患者的AF史 (11.5%) 与不良结果有关.
- POAF的发病率为3.6%,在内血管手术中风险降低.
- 需要进一步的随机试验来评估口服抗凝剂对于AF相关的中风预防.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Aneurysm IV: Nursing Management
8
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
8
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
42
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
42
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19


